Syncom Formulations (India) Limited Stock: price and insider trades · India
Syncom Formulations (India) Limited: what insiders have been doing
Syncom Formulations (India) Limited has a thin disclosure history in our data (latest filing: 16 June 2023). New filings will appear here as soon as they are published. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.
Insider Decl.
2
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 7,452 of 26,911 companies
62.7
score / 100
Value44
Quality81
FCF yld2.3%
Earn yld3.8%
EV/EBITDA18.6x
ROE20%
Gross mgn39%
Net mgn16%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
₹23.28
Analyst consensus
Income statement
Revenue₹4.8B
Gross profit₹1.9B39% margin
EBITDA₹1.1B22% margin
Net income₹764.4M17.2% margin
Valuation
PER (trailing)24.8x
P/Book5.2x
Beta0.83
Balance sheet & cash
Market cap₹21.9B
Total debt₹14.9M
Free Cash Flow₹464.1M
Debt / Equity0%
Profitability & ownership
ROE20.2%
ROA9.4%
% insiders50.6%
% institutions0.1%
Last declaration on 16 June 2023
Declarations2 total
- 2,731,470 sharesEquity SharesSEBI:7b4fd1dc53b21e8a05f9ca5359dbc51af74612fc
- 2,731,470 sharesEquity SharesSEBI:4313174d62111083eda508ae41b35ffc583010eb
2 of 2 declarations
About Syncom Formulations (India) Limited
Syncom Formulations (India) Limited is a company engaged in the manufacturing of pharmaceutical products. It operates in the healthcare and pharmaceutical sector in India.
